Effects of tamoxifen vs raloxifene on proliferative activity in breast tissue in women who underwent subsequent surgical excision of benign breast nodules

Trial Profile

Effects of tamoxifen vs raloxifene on proliferative activity in breast tissue in women who underwent subsequent surgical excision of benign breast nodules

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Jan 2014

At a glance

  • Drugs Raloxifene (Primary) ; Tamoxifen (Primary)
  • Indications Breast cancer
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 16 Jan 2014 New trial record
    • 14 Dec 2013 Results presented at the 36th Annual San Antonio Breast Cancer Symposium.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top